Evidence map›Paper›PMID 27595568›Full record

ArticleRetrovirology2016

Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Corinna S Oberle, Beda Joos, Peter Rusert, Nottania K Campbell, David Beauparlant, Herbert Kuster, Jacqueline Weber, Corinne D Schenkel, Alexandra U Scherrer, Carsten Magnus and 13 more

Abstract read
In one paragraph

Article in Retrovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Corinna S OberleDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Beda JoosDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Peter RusertInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Nottania K CampbellDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
David BeauparlantInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Herbert KusterDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Jacqueline WeberInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Corinne D SchenkelDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Alexandra U ScherrerDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Carsten MagnusInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Roger KouyosDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Philip RiederDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Barbara NiederöstDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Dominique L BraunDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Jovan PavlovicInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Jürg BöniInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Sabine YerlyLaboratory of Virology, University Hospital Geneva, University of Geneva, Geneva, Switzerland.
Thomas KlimkaitDepartment of Biomedicine, University of Basel, Basel, Switzerland.
Vincent AubertDivision of Immunology and Allergy, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland.
Alexandra TrkolaInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Karin J MetznerDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. huldrych.guenthard@usz.ch.
Swiss HIV Cohort Study (SHCS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMucosal HIV-1 transmission predominantly results in a single transmitted/founder (T/F) virus establishing infection in the new host despite the generally high genetic diversity of the transmitter virus population. To what extent HIV-1 transmission is a stochastic process or driven by selective forces that allow T/F viruses best to overcome bottlenecks in transmission has not been conclusively resolved. Building on prior investigations that suggest HIV-1 envelope (Env) features to contribute in the selection process during transmission, we compared phenotypic virus characteristics of nine HIV-1 subtype B transmission pairs, six men who have sex with men and three male-to-female transmission pairs.

resultsAll recipients were identified early in acute infection and harbored based on extensive sequencing analysis a single T/F virus allowing a controlled analysis of virus properties in matched transmission pairs. Recipient and transmitter viruses from the closest time point to transmission showed no signs of selection for specific Env modifications such as variable loop length and glycosylation. Recipient viruses were resistant to circulating plasma antibodies of the transmitter and also showed no altered sensitivity to a large panel of entry inhibitors and neutralizing antibodies. The recipient virus did not consistently differ from the transmitter virus in terms of entry kinetics, cell-cell transmission and replicative capacity in primary cells. Our paired analysis revealed a higher sensitivity of several recipient virus isolates to interferon-α (IFNα) which suggests that resistance to IFNα cannot be a general driving force in T/F establishment.

conclusionsWith the exception of increased IFNα sensitivity, none of the phenotypic virus properties we investigated clearly distinguished T/F viruses from their matched transmitter viruses supporting the notion that at least in subtype B infection HIV-1 transmission is to a considerable extent stochastic.

Indexed as

Acute DiseaseAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusFemaleGenetic VariationHIV-1HIV InfectionsHomosexuality, MaleHumansInterferon-alphaLeukocytes, MononuclearMaleNeutralization TestsPhenotypeSequence Analysis, DNAStochastic ProcessesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusInterferon-alphaEntryEnvelopeHIV-1IFNαNeutralizationReplicative capacityTransmission

Identifiers

PMID27595568
PMCPMC5011806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.